APO Research
Talk to an analyst

APO RESEARCH · REPORT

Azelastine

Azelastine is an antihistamine. It works by preventing the effects of a substance called histamine, which produced by the body. Histamine can cause itching, sneezing, runny nose, and watery eyes.

Explore the product
View pricing & licenses

Product & engineering

Understand the product.

Azelastine is an antihistamine. It works by preventing the effects of a substance called histamine, which produced by the body. Histamine can cause itching, sneezing, runny nose, and watery eyes.

Azelastine is a medication primarily used as a nasal spray to treat hay fever and allergy symptoms including runny nose, sneezing, and itchy nose and as eye drops for allergic conjunctivitis. Other uses may include asthma and skin rashes for which is taken by mouth

Selected research

Market Outlook & Growth Opportunities

Global Azelastine Market Outlook and Growth Opportunities 2026

29 December 2025191 pages

Choose your research edition.

Industry ResearchAzelastine Industry Research Report 2026123 pages · $2,950 USDIndustry Growth & TrendsGlobal Azelastine Industry Growth and Trends Forecast to 2032106 pages · $3,450 USDMarket StructureGlobal Azelastine Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032190 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Azelastine Market Outlook and Growth Opportunities 2026191 pages · $4,250 USDMarket Analysis & ForecastGlobal Azelastine Market Analysis and Forecast 2026-2032191 pages · $4,950 USD

Market perspective

Azelastine is an antihistamine. It works by preventing the effects of a substance called histamine, which produced by the body. Histamine can cause itching, sneezing, runny nose, and watery eyes.

Azelastine is a medication primarily used as a nasal spray to treat hay fever and allergy symptoms including runny nose, sneezing, and itchy nose and as eye drops for allergic conjunctivitis. Other uses may include asthma and skin rashes for which is taken by mouth

Global Azelastine includes Viatris, Apotex, Yunfeng Pharma, Sun Pharma, Amneal Pharmaceuticals, Zhongsheng Pharma, Hikma Pharmaceuticals, Perrigo, Alkem Labs and Jiangxi Zhenshiming Pharmaceutical, etc. Global top 3 companies hold a share over 57%. Asia-Pacific is the largest market, with a share about 40%, followed by Europe and North America with the share approximately 20% each.

Read the full market overview

This report provides an overview of the global Azelastine market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Azelastine and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Azelastine sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Azelastine market size, projected growth trends, production technologies, key applications, and end-use industries.

Azelastine Segment by Company

Viatris

Apotex

Yunfeng Pharma

Sun Pharma

Amneal Pharmaceuticals

Zhongsheng Pharma

Hikma Pharmaceuticals

Perrigo

Alkem Labs

Jiangxi Zhenshiming Pharmaceutical

Azelastine Segment by Type

Nasal Spray

Eye Drops

Others

Azelastine Segment by Distribution Channel

Hospital

Retail Pharmacy

Others

Azelastine Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global Azelastine status and future forecast, involving, sales, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions Azelastine market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Azelastine significant trends, drivers, influence factors in global and regions.

6. To analyze Azelastine competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Azelastine market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Azelastine and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Azelastine.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Azelastine market, including product definition, global market growth prospects, sales value, sales volume, and average price forecasts (2021-2032).

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Azelastine industry.

Chapter 3: Detailed analysis of Azelastine manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales and value of Azelastine in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.

Chapter 7: Sales and value of Azelastine in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Azelastine Industry Trends Table 2. Azelastine Industry Drivers Table 3. Azelastine Industry Opportunities and Challenges Table 4. Azelastine Industry Restraints Table 5. Global Azelastine Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Azelastine Revenue Share by Company (2021-2026) Table 7. Global Azelastine Sales Volume by Company (K Units) & (2021-2026) Table 8. Global Azelastine Sales Volume Share by Company (2021-2026) Table 9. Global Azelastine Average Price (US$/Unit) of Company (2021-2026) Table 10. Global Azelastine Company Ranking, (2024-2026) & (USD Million) Table 11. Global Azelastine Key Company Manufacturing Base & Headquarters Table 12. Global Azelastine Company, Product Type & Application Table 13. Global Azelastine Company Establishment Date Table 14. Global Company Market Concentration Ratio (CR5 and HHI) Table 15. Global Azelastine by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 16. Mergers & Acquisitions, Expansion Table 17. Significant Companies of Nasal Spray Table 18. Significant Companies of Eye Drops Table 19. Significant Companies of Others Table 20. Global Azelastine Sales Volume by Type 2021 VS 2025 VS 2032 (K Units) Table 21. Global Azelastine Sales Volume by Type (2021-2026) & (K Units) Table 22. Global Azelastine Sales Volume by Type (2027-2032) & (K Units) Table 23. Global Azelastine Sales Volume Share by Type (2021-2026) Table 24. Global Azelastine Sales Volume Share by Type (2027-2032) Table 25. Global Azelastine Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 26. Global Azelastine Sales Value by Type (2021-2026) & (US$ Million) Table 27. Global Azelastine Sales Value by Type (2027-2032) & (US$ Million) Table 28. Global Azelastine Sales Value Share by Type (2021-2026) Table 29. Global Azelastine Sales Value Share by Type (2027-2032) Table 30. Significant Companies of Hospital Table 31. Significant Companies of Retail Pharmacy Table 32. Significant Companies of Others Table 33. Global Azelastine Sales Volume by Application 2021 VS 2025 VS 2032 (K Units) Table 34. Global Azelastine Sales Volume by Application (2021-2026) & (K Units) Table 35. Global Azelastine Sales Volume by Application (2027-2032) & (K Units) Table 36. Global Azelastine Sales Volume Share by Application (2021-2026) Table 37. Global Azelastine Sales Volume Share by Application (2027-2032) Table 38. Global Azelastine Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 39. Global Azelastine Sales Value by Application (2021-2026) & (US$ Million) Table 40. Global Azelastine Sales Value by Application (2027-2032) & (US$ Million) Table 41. Global Azelastine Sales Value Share by Application (2021-2026) Table 42. Global Azelastine Sales Value Share by Application (2027-2032) Table 43. Global Azelastine Sales by Region: 2021 VS 2025 VS 2032 (K Units) Table 44. Global Azelastine Sales by Region (2021-2026) & (K Units) Table 45. Global Azelastine Sales Market Share by Region (2021-2026) Table 46. Global Azelastine Sales by Region (2027-2032) & (K Units) Table 47. Global Azelastine Sales Market Share by Region (2027-2032) Table 48. Global Azelastine Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 49. Global Azelastine Sales Value by Region (2021-2026) & (US$ Million) Table 50. Global Azelastine Sales Value Share by Region (2021-2026) Table 51. Global Azelastine Sales Value by Region (2027-2032) & (US$ Million) Table 52. Global Azelastine Sales Value Share by Region (2027-2032) Table 53. Global Azelastine Market Average Price (US$/Unit) by Region (2021-2026) Table 54. Global Azelastine Market Average Price (US$/Unit) by Region (2027-2032) Table 55. Global Azelastine Sales by Country: 2021 VS 2025 VS 2032 (K Units) Table 56. Global Azelastine Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 57. Global Azelastine Sales by Country (2021-2026) & (K Units) Table 58. Global Azelastine Sales Market Share by Country (2021-2026) Table 59. Global Azelastine Sales by Country (2027-2032) & (K Units) Table 60. Global Azelastine Sales Market Share by Country (2027-2032) Table 61. Global Azelastine Sales Value by Country (2021-2026) & (US$ Million) Table 62. Global Azelastine Sales Value Market Share by Country (2021-2026) Table 63. Global Azelastine Sales Value by Country (2027-2032) & (US$ Million) Table 64. Global Azelastine Sales Value Market Share by Country (2027-2032) Table 65. Viatris Company Information Table 66. Viatris Business Overview Table 67. Viatris Azelastine Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 68. Viatris Azelastine Product Portfolio Table 69. Viatris Recent Development Table 70. Apotex Company Information Table 71. Apotex Business Overview Table 72. Apotex Azelastine Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 73. Apotex Azelastine Product Portfolio Table 74. Apotex Recent Development Table 75. Yunfeng Pharma Company Information Table 76. Yunfeng Pharma Business Overview Table 77. Yunfeng Pharma Azelastine Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 78. Yunfeng Pharma Azelastine Product Portfolio Table 79. Yunfeng Pharma Recent Development Table 80. Sun Pharma Company Information Table 81. Sun Pharma Business Overview Table 82. Sun Pharma Azelastine Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 83. Sun Pharma Azelastine Product Portfolio Table 84. Sun Pharma Recent Development Table 85. Amneal Pharmaceuticals Company Information Table 86. Amneal Pharmaceuticals Business Overview Table 87. Amneal Pharmaceuticals Azelastine Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 88. Amneal Pharmaceuticals Azelastine Product Portfolio Table 89. Amneal Pharmaceuticals Recent Development Table 90. Zhongsheng Pharma Company Information Table 91. Zhongsheng Pharma Business Overview Table 92. Zhongsheng Pharma Azelastine Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 93. Zhongsheng Pharma Azelastine Product Portfolio Table 94. Zhongsheng Pharma Recent Development Table 95. Hikma Pharmaceuticals Company Information Table 96. Hikma Pharmaceuticals Business Overview Table 97. Hikma Pharmaceuticals Azelastine Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 98. Hikma Pharmaceuticals Azelastine Product Portfolio Table 99. Hikma Pharmaceuticals Recent Development Table 100. Perrigo Company Information Table 101. Perrigo Business Overview Table 102. Perrigo Azelastine Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 103. Perrigo Azelastine Product Portfolio Table 104. Perrigo Recent Development Table 105. Alkem Labs Company Information Table 106. Alkem Labs Business Overview Table 107. Alkem Labs Azelastine Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 108. Alkem Labs Azelastine Product Portfolio Table 109. Alkem Labs Recent Development Table 110. Jiangxi Zhenshiming Pharmaceutical Company Information Table 111. Jiangxi Zhenshiming Pharmaceutical Business Overview Table 112. Jiangxi Zhenshiming Pharmaceutical Azelastine Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 113. Jiangxi Zhenshiming Pharmaceutical Azelastine Product Portfolio Table 114. Jiangxi Zhenshiming Pharmaceutical Recent Development Table 115. Key Raw Materials Table 116. Raw Materials Key Suppliers Table 117. Azelastine Distributors List Table 118. Azelastine Customers List Table 119. Research Programs/Design for This Report Table 120. Authors List of This Report Table 121. Secondary Sources Table 122. Primary Sources List of Figures Figure 1. Azelastine Product Image Figure 2. Global Azelastine Sales Value (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Azelastine Sales Value (2021-2032) & (US$ Million) Figure 4. Global Azelastine Sales (2021-2032) & (K Units) Figure 5. Global Azelastine Sales Average Price (US$/Unit) & (2021-2032) Figure 6. Global Azelastine Company Revenue Ranking in 2025 (US$ Million) Figure 7. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 8. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 9. Nasal Spray Image Figure 10. Eye Drops Image Figure 11. Others Image Figure 12. Global Azelastine Sales Volume by Type (2021 VS 2025 VS 2032) & (K Units) Figure 13. Global Azelastine Sales Volume Share 2021 VS 2025 VS 2032 Figure 14. Global Azelastine Sales Volume Share by Type (2021-2032) Figure 15. Global Azelastine Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 16. Global Azelastine Sales Value Share 2021 VS 2025 VS 2032 Figure 17. Global Azelastine Sales Value Share by Type (2021-2032) Figure 18. Hospital Image Figure 19. Retail Pharmacy Image Figure 20. Others Image Figure 21. Global Azelastine Sales Volume by Application (2021 VS 2025 VS 2032) & (K Units) Figure 22. Global Azelastine Sales Volume Share 2021 VS 2025 VS 2032 Figure 23. Global Azelastine Sales Volume Share by Application (2021-2032) Figure 24. Global Azelastine Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 25. Global Azelastine Sales Value Share 2021 VS 2025 VS 2032 Figure 26. Global Azelastine Sales Value Share by Application (2021-2032) Figure 27. Global Azelastine Sales by Region: 2021 VS 2025 VS 2032 (K Units) Figure 28. Global Azelastine Sales Market Share by Region: 2021 VS 2025 VS 2032 Figure 29. Global Azelastine Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 30. Global Azelastine Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 31. North America Azelastine Sales Value (2021-2032) & (US$ Million) Figure 32. North America Azelastine Sales Value Share by Country (%), 2025 VS 2032 Figure 33. Europe Azelastine Sales Value (2021-2032) & (US$ Million) Figure 34. Europe Azelastine Sales Value Share by Country (%), 2025 VS 2032 Figure 35. Asia-Pacific Azelastine Sales Value (2021-2032) & (US$ Million) Figure 36. Asia-Pacific Azelastine Sales Value Share by Country (%), 2025 VS 2032 Figure 37. South America Azelastine Sales Value (2021-2032) & (US$ Million) Figure 38. South America Azelastine Sales Value Share by Country (%), 2025 VS 2032 Figure 39. Middle East & Africa Azelastine Sales Value (2021-2032) & (US$ Million) Figure 40. Middle East & Africa Azelastine Sales Value Share by Country (%), 2025 VS 2032 Figure 41. USA Azelastine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 42. USA Azelastine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 43. USA Azelastine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 44. Canada Azelastine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 45. Canada Azelastine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 46. Canada Azelastine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 47. Mexico Azelastine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 48. Mexico Azelastine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 49. Mexico Azelastine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 50. Germany Azelastine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 51. Germany Azelastine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 52. Germany Azelastine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 53. France Azelastine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 54. France Azelastine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 55. France Azelastine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 56. U.K. Azelastine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 57. U.K. Azelastine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 58. U.K. Azelastine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 59. Italy Azelastine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 60. Italy Azelastine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 61. Italy Azelastine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 62. Spain Azelastine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 63. Spain Azelastine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 64. Spain Azelastine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 65. Russia Azelastine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 66. Russia Azelastine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 67. Russia Azelastine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 68. Netherlands Azelastine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 69. Netherlands Azelastine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 70. Netherlands Azelastine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 71. Nordic Countries Azelastine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 72. Nordic Countries Azelastine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 73. Nordic Countries Azelastine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 74. China Azelastine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 75. China Azelastine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 76. China Azelastine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 77. Japan Azelastine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 78. Japan Azelastine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 79. Japan Azelastine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 80. South Korea Azelastine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 81. South Korea Azelastine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 82. South Korea Azelastine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 83. India Azelastine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 84. India Azelastine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 85. India Azelastine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 86. Australia Azelastine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 87. Australia Azelastine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 88. Australia Azelastine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 89. Southeast Asia Azelastine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 90. Southeast Asia Azelastine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 91. Southeast Asia Azelastine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 92. Brazil Azelastine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 93. Brazil Azelastine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 94. Brazil Azelastine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 95. Argentina Azelastine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 96. Argentina Azelastine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 97. Argentina Azelastine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 98. Chile Azelastine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 99. Chile Azelastine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 100. Chile Azelastine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 101. Colombia Azelastine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 102. Colombia Azelastine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 103. Colombia Azelastine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 104. Peru Azelastine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 105. Peru Azelastine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 106. Peru Azelastine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 107. Saudi Arabia Azelastine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 108. Saudi Arabia Azelastine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 109. Saudi Arabia Azelastine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 110. Israel Azelastine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 111. Israel Arabia Azelastine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 112. Israel Arabia Azelastine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 113. UAE Azelastine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 114. UAE Azelastine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 115. UAE Azelastine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 116. Turkey Azelastine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 117. Turkey Azelastine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 118. Turkey Azelastine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 119. Iran Azelastine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 120. Iran Azelastine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 121. Iran Azelastine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 122. Egypt Azelastine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 123. Egypt Azelastine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 124. Egypt Azelastine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 125. Azelastine Value Chain Figure 126. Manufacturing Cost Structure Figure 127. Azelastine Sales Mode & Process Figure 128. Direct Comparison with Distribution Share Figure 129. Distributors Profiles Figure 130. Years Considered Figure 131. Research Process Figure 132. Key Executives Interviewed

Scope & coverage.

Types
  • Nasal Spray
  • Eye Drops
  • Others
Applications
  • Hospital
  • Retail Pharmacy
  • Others
Companies covered
  • Viatris
  • Apotex
  • Yunfeng Pharma
  • Sun Pharma
  • Amneal Pharmaceuticals
  • Zhongsheng Pharma
  • Hikma Pharmaceuticals
  • Perrigo
  • Alkem Labs
  • Jiangxi Zhenshiming Pharmaceutical

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Azelastine Sales Value (2021-2032)
  4. 1.2.2 Global Azelastine Sales Volume (2021-2032)
  5. 1.2.3 Global Azelastine Sales Average Price (2021-2032)
  6. 1.3 Assumptions and Limitations
  7. 1.4 Study Goals and Objectives
2 Azelastine Market Dynamics
  1. 2.1 Azelastine Industry Trends
  2. 2.2 Azelastine Industry Drivers
  3. 2.3 Azelastine Industry Opportunities and Challenges
  4. 2.4 Azelastine Industry Restraints
3 Azelastine Market by Company
  1. 3.1 Global Azelastine Company Revenue Ranking in 2025
  2. 3.2 Global Azelastine Revenue by Company (2021-2026)
  3. 3.3 Global Azelastine Sales Volume by Company (2021-2026)
  4. 3.4 Global Azelastine Average Price by Company (2021-2026)
  5. 3.5 Global Azelastine Company Ranking (2024-2026)
  6. 3.6 Global Azelastine Company Manufacturing Base and Headquarters
  7. 3.7 Global Azelastine Company Product Type and Application
  8. 3.8 Global Azelastine Company Establishment Date
  9. 3.9 Market Competitive Analysis
  10. 3.9.1 Global Azelastine Market Concentration Ratio (CR5 and HHI)
  11. 3.9.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  12. 3.9.3 2025 Azelastine Tier 1, Tier 2, and Tier 3 Companies
  13. 3.10 Mergers and Acquisitions Expansion
4 Azelastine Market by Type
  1. 4.1 Azelastine Type Introduction
  2. 4.1.1 Nasal Spray
  3. 4.1.2 Eye Drops
  4. 4.1.3 Others
  5. 4.2 Global Azelastine Sales Volume by Type
  6. 4.2.1 Global Azelastine Sales Volume by Type (2021 VS 2025 VS 2032)
  7. 4.2.2 Global Azelastine Sales Volume by Type (2021-2032)
  8. 4.2.3 Global Azelastine Sales Volume Share by Type (2021-2032)
  9. 4.3 Global Azelastine Sales Value by Type
  10. 4.3.1 Global Azelastine Sales Value by Type (2021 VS 2025 VS 2032)
  11. 4.3.2 Global Azelastine Sales Value by Type (2021-2032)
  12. 4.3.3 Global Azelastine Sales Value Share by Type (2021-2032)
5 Azelastine Market by Application
  1. 5.1 Azelastine Application Introduction
  2. 5.1.1 Hospital
  3. 5.1.2 Retail Pharmacy
  4. 5.1.3 Others
  5. 5.2 Global Azelastine Sales Volume by Application
  6. 5.2.1 Global Azelastine Sales Volume by Application (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Azelastine Sales Volume by Application (2021-2032)
  8. 5.2.3 Global Azelastine Sales Volume Share by Application (2021-2032)
  9. 5.3 Global Azelastine Sales Value by Application
  10. 5.3.1 Global Azelastine Sales Value by Application (2021 VS 2025 VS 2032)
  11. 5.3.2 Global Azelastine Sales Value by Application (2021-2032)
  12. 5.3.3 Global Azelastine Sales Value Share by Application (2021-2032)
6 Azelastine Regional Sales and Value Analysis
  1. 6.1 Global Azelastine Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Azelastine Sales by Region (2021-2032)
  3. 6.2.1 Global Azelastine Sales by Region: 2021-2026
  4. 6.2.2 Global Azelastine Sales by Region (2027-2032)
  5. 6.3 Global Azelastine Sales Value by Region: 2021 VS 2025 VS 2032
  6. 6.4 Global Azelastine Sales Value by Region (2021-2032)
  7. 6.4.1 Global Azelastine Sales Value by Region: 2021-2026
  8. 6.4.2 Global Azelastine Sales Value by Region (2027-2032)
  9. 6.5 Global Azelastine Market Price Analysis by Region (2021-2026)
  10. 6.6 North America
  11. 6.6.1 North America Azelastine Sales Value (2021-2032)
  12. 6.6.2 North America Azelastine Sales Value Share by Country, 2025 VS 2032
  13. 6.7 Europe
  14. 6.7.1 Europe Azelastine Sales Value (2021-2032)
  15. 6.7.2 Europe Azelastine Sales Value Share by Country, 2025 VS 2032
  16. 6.8 Asia-Pacific
  17. 6.8.1 Asia-Pacific Azelastine Sales Value (2021-2032)
  18. 6.8.2 Asia-Pacific Azelastine Sales Value Share by Country, 2025 VS 2032
  19. 6.9 South America
  20. 6.9.1 South America Azelastine Sales Value (2021-2032)
  21. 6.9.2 South America Azelastine Sales Value Share by Country, 2025 VS 2032
  22. 6.10 Middle East & Africa
  23. 6.10.1 Middle East & Africa Azelastine Sales Value (2021-2032)
  24. 6.10.2 Middle East & Africa Azelastine Sales Value Share by Country, 2025 VS 2032
7 Azelastine Country-level Sales and Value Analysis
  1. 7.1 Global Azelastine Sales by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Azelastine Sales Value by Country: 2021 VS 2025 VS 2032
  3. 7.3 Global Azelastine Sales by Country (2021-2032)
  4. 7.3.1 Global Azelastine Sales by Country (2021-2026)
  5. 7.3.2 Global Azelastine Sales by Country (2027-2032)
  6. 7.4 Global Azelastine Sales Value by Country (2021-2032)
  7. 7.4.1 Global Azelastine Sales Value by Country (2021-2026)
  8. 7.4.2 Global Azelastine Sales Value by Country (2027-2032)
  9. 7.5 USA
  10. 7.5.1 USA Azelastine Sales Value Growth Rate (2021-2032)
  11. 7.5.2 USA Azelastine Sales Value Share by Type, 2025 VS 2032
  12. 7.5.3 USA Azelastine Sales Value Share by Application, 2025 VS 2032
  13. 7.6 Canada
  14. 7.6.1 Canada Azelastine Sales Value Growth Rate (2021-2032)
  15. 7.6.2 Canada Azelastine Sales Value Share by Type, 2025 VS 2032
  16. 7.6.3 Canada Azelastine Sales Value Share by Application, 2025 VS 2032
  17. 7.7 Mexico
  18. 7.6.1 Mexico Azelastine Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Mexico Azelastine Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Mexico Azelastine Sales Value Share by Application, 2025 VS 2032
  21. 7.8 Germany
  22. 7.8.1 Germany Azelastine Sales Value Growth Rate (2021-2032)
  23. 7.8.2 Germany Azelastine Sales Value Share by Type, 2025 VS 2032
  24. 7.8.3 Germany Azelastine Sales Value Share by Application, 2025 VS 2032
  25. 7.9 France
  26. 7.9.1 France Azelastine Sales Value Growth Rate (2021-2032)
  27. 7.9.2 France Azelastine Sales Value Share by Type, 2025 VS 2032
  28. 7.9.3 France Azelastine Sales Value Share by Application, 2025 VS 2032
  29. 7.10 U.K.
  30. 7.10.1 U.K. Azelastine Sales Value Growth Rate (2021-2032)
  31. 7.10.2 U.K. Azelastine Sales Value Share by Type, 2025 VS 2032
  32. 7.10.3 U.K. Azelastine Sales Value Share by Application, 2025 VS 2032
  33. 7.11 Italy
  34. 7.11.1 Italy Azelastine Sales Value Growth Rate (2021-2032)
  35. 7.11.2 Italy Azelastine Sales Value Share by Type, 2025 VS 2032
  36. 7.11.3 Italy Azelastine Sales Value Share by Application, 2025 VS 2032
  37. 7.12 Spain
  38. 7.12.1 Spain Azelastine Sales Value Growth Rate (2021-2032)
  39. 7.12.2 Spain Azelastine Sales Value Share by Type, 2025 VS 2032
  40. 7.12.3 Spain Azelastine Sales Value Share by Application, 2025 VS 2032
  41. 7.13 Russia
  42. 7.13.1 Russia Azelastine Sales Value Growth Rate (2021-2032)
  43. 7.13.2 Russia Azelastine Sales Value Share by Type, 2025 VS 2032
  44. 7.13.3 Russia Azelastine Sales Value Share by Application, 2025 VS 2032
  45. 7.14 Netherlands
  46. 7.14.1 Netherlands Azelastine Sales Value Growth Rate (2021-2032)
  47. 7.14.2 Netherlands Azelastine Sales Value Share by Type, 2025 VS 2032
  48. 7.14.3 Netherlands Azelastine Sales Value Share by Application, 2025 VS 2032
  49. 7.15 Nordic Countries
  50. 7.15.1 Nordic Countries Azelastine Sales Value Growth Rate (2021-2032)
  51. 7.15.2 Nordic Countries Azelastine Sales Value Share by Type, 2025 VS 2032
  52. 7.15.3 Nordic Countries Azelastine Sales Value Share by Application, 2025 VS 2032
  53. 7.16 China
  54. 7.16.1 China Azelastine Sales Value Growth Rate (2021-2032)
  55. 7.16.2 China Azelastine Sales Value Share by Type, 2025 VS 2032
  56. 7.16.3 China Azelastine Sales Value Share by Application, 2025 VS 2032
  57. 7.17 Japan
  58. 7.17.1 Japan Azelastine Sales Value Growth Rate (2021-2032)
  59. 7.17.2 Japan Azelastine Sales Value Share by Type, 2025 VS 2032
  60. 7.17.3 Japan Azelastine Sales Value Share by Application, 2025 VS 2032
  61. 7.18 South Korea
  62. 7.18.1 South Korea Azelastine Sales Value Growth Rate (2021-2032)
  63. 7.18.2 South Korea Azelastine Sales Value Share by Type, 2025 VS 2032
  64. 7.18.3 South Korea Azelastine Sales Value Share by Application, 2025 VS 2032
  65. 7.19 India
  66. 7.19.1 India Azelastine Sales Value Growth Rate (2021-2032)
  67. 7.19.2 India Azelastine Sales Value Share by Type, 2025 VS 2032
  68. 7.19.3 India Azelastine Sales Value Share by Application, 2025 VS 2032
  69. 7.20 Australia
  70. 7.20.1 Australia Azelastine Sales Value Growth Rate (2021-2032)
  71. 7.20.2 Australia Azelastine Sales Value Share by Type, 2025 VS 2032
  72. 7.20.3 Australia Azelastine Sales Value Share by Application, 2025 VS 2032
  73. 7.21 Southeast Asia
  74. 7.21.1 Southeast Asia Azelastine Sales Value Growth Rate (2021-2032)
  75. 7.21.2 Southeast Asia Azelastine Sales Value Share by Type, 2025 VS 2032
  76. 7.21.3 Southeast Asia Azelastine Sales Value Share by Application, 2025 VS 2032
  77. 7.22 Brazil
  78. 7.22.1 Brazil Azelastine Sales Value Growth Rate (2021-2032)
  79. 7.22.2 Brazil Azelastine Sales Value Share by Type, 2025 VS 2032
  80. 7.22.3 Brazil Azelastine Sales Value Share by Application, 2025 VS 2032
  81. 7.23 Argentina
  82. 7.23.1 Argentina Azelastine Sales Value Growth Rate (2021-2032)
  83. 7.23.2 Argentina Azelastine Sales Value Share by Type, 2025 VS 2032
  84. 7.23.3 Argentina Azelastine Sales Value Share by Application, 2025 VS 2032
  85. 7.24 Chile
  86. 7.24.1 Chile Azelastine Sales Value Growth Rate (2021-2032)
  87. 7.24.2 Chile Azelastine Sales Value Share by Type, 2025 VS 2032
  88. 7.24.3 Chile Azelastine Sales Value Share by Application, 2025 VS 2032
  89. 7.25 Colombia
  90. 7.25.1 Colombia Azelastine Sales Value Growth Rate (2021-2032)
  91. 7.25.2 Colombia Azelastine Sales Value Share by Type, 2025 VS 2032
  92. 7.25.3 Colombia Azelastine Sales Value Share by Application, 2025 VS 2032
  93. 7.26 Peru
  94. 7.26.1 Peru Azelastine Sales Value Growth Rate (2021-2032)
  95. 7.26.2 Peru Azelastine Sales Value Share by Type, 2025 VS 2032
  96. 7.26.3 Peru Azelastine Sales Value Share by Application, 2025 VS 2032
  97. 7.27 Saudi Arabia
  98. 7.27.1 Saudi Arabia Azelastine Sales Value Growth Rate (2021-2032)
  99. 7.27.2 Saudi Arabia Azelastine Sales Value Share by Type, 2025 VS 2032
  100. 7.27.3 Saudi Arabia Azelastine Sales Value Share by Application, 2025 VS 2032
  101. 7.28 Israel
  102. 7.28.1 Israel Azelastine Sales Value Growth Rate (2021-2032)
  103. 7.28.2 Israel Azelastine Sales Value Share by Type, 2025 VS 2032
  104. 7.28.3 Israel Azelastine Sales Value Share by Application, 2025 VS 2032
  105. 7.29 UAE
  106. 7.29.1 UAE Azelastine Sales Value Growth Rate (2021-2032)
  107. 7.29.2 UAE Azelastine Sales Value Share by Type, 2025 VS 2032
  108. 7.29.3 UAE Azelastine Sales Value Share by Application, 2025 VS 2032
  109. 7.30 Turkey
  110. 7.30.1 Turkey Azelastine Sales Value Growth Rate (2021-2032)
  111. 7.30.2 Turkey Azelastine Sales Value Share by Type, 2025 VS 2032
  112. 7.30.3 Turkey Azelastine Sales Value Share by Application, 2025 VS 2032
  113. 7.31 Iran
  114. 7.31.1 Iran Azelastine Sales Value Growth Rate (2021-2032)
  115. 7.31.2 Iran Azelastine Sales Value Share by Type, 2025 VS 2032
  116. 7.31.3 Iran Azelastine Sales Value Share by Application, 2025 VS 2032
  117. 7.32 Egypt
  118. 7.32.1 Egypt Azelastine Sales Value Growth Rate (2021-2032)
  119. 7.32.2 Egypt Azelastine Sales Value Share by Type, 2025 VS 2032
  120. 7.32.3 Egypt Azelastine Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 Viatris
  2. 8.1.1 Viatris Company Information
  3. 8.1.2 Viatris Business Overview
  4. 8.1.3 Viatris Azelastine Sales, Value and Gross Margin (2021-2026)
  5. 8.1.4 Viatris Azelastine Product Portfolio
  6. 8.1.5 Viatris Recent Developments
  7. 8.2 Apotex
  8. 8.2.1 Apotex Company Information
  9. 8.2.2 Apotex Business Overview
  10. 8.2.3 Apotex Azelastine Sales, Value and Gross Margin (2021-2026)
  11. 8.2.4 Apotex Azelastine Product Portfolio
  12. 8.2.5 Apotex Recent Developments
  13. 8.3 Yunfeng Pharma
  14. 8.3.1 Yunfeng Pharma Company Information
  15. 8.3.2 Yunfeng Pharma Business Overview
  16. 8.3.3 Yunfeng Pharma Azelastine Sales, Value and Gross Margin (2021-2026)
  17. 8.3.4 Yunfeng Pharma Azelastine Product Portfolio
  18. 8.3.5 Yunfeng Pharma Recent Developments
  19. 8.4 Sun Pharma
  20. 8.4.1 Sun Pharma Company Information
  21. 8.4.2 Sun Pharma Business Overview
  22. 8.4.3 Sun Pharma Azelastine Sales, Value and Gross Margin (2021-2026)
  23. 8.4.4 Sun Pharma Azelastine Product Portfolio
  24. 8.4.5 Sun Pharma Recent Developments
  25. 8.5 Amneal Pharmaceuticals
  26. 8.5.1 Amneal Pharmaceuticals Company Information
  27. 8.5.2 Amneal Pharmaceuticals Business Overview
  28. 8.5.3 Amneal Pharmaceuticals Azelastine Sales, Value and Gross Margin (2021-2026)
  29. 8.5.4 Amneal Pharmaceuticals Azelastine Product Portfolio
  30. 8.5.5 Amneal Pharmaceuticals Recent Developments
  31. 8.6 Zhongsheng Pharma
  32. 8.6.1 Zhongsheng Pharma Company Information
  33. 8.6.2 Zhongsheng Pharma Business Overview
  34. 8.6.3 Zhongsheng Pharma Azelastine Sales, Value and Gross Margin (2021-2026)
  35. 8.6.4 Zhongsheng Pharma Azelastine Product Portfolio
  36. 8.6.5 Zhongsheng Pharma Recent Developments
  37. 8.7 Hikma Pharmaceuticals
  38. 8.7.1 Hikma Pharmaceuticals Company Information
  39. 8.7.2 Hikma Pharmaceuticals Business Overview
  40. 8.7.3 Hikma Pharmaceuticals Azelastine Sales, Value and Gross Margin (2021-2026)
  41. 8.7.4 Hikma Pharmaceuticals Azelastine Product Portfolio
  42. 8.7.5 Hikma Pharmaceuticals Recent Developments
  43. 8.8 Perrigo
  44. 8.8.1 Perrigo Company Information
  45. 8.8.2 Perrigo Business Overview
  46. 8.8.3 Perrigo Azelastine Sales, Value and Gross Margin (2021-2026)
  47. 8.8.4 Perrigo Azelastine Product Portfolio
  48. 8.8.5 Perrigo Recent Developments
  49. 8.9 Alkem Labs
  50. 8.9.1 Alkem Labs Company Information
  51. 8.9.2 Alkem Labs Business Overview
  52. 8.9.3 Alkem Labs Azelastine Sales, Value and Gross Margin (2021-2026)
  53. 8.9.4 Alkem Labs Azelastine Product Portfolio
  54. 8.9.5 Alkem Labs Recent Developments
  55. 8.10 Jiangxi Zhenshiming Pharmaceutical
  56. 8.10.1 Jiangxi Zhenshiming Pharmaceutical Company Information
  57. 8.10.2 Jiangxi Zhenshiming Pharmaceutical Business Overview
  58. 8.10.3 Jiangxi Zhenshiming Pharmaceutical Azelastine Sales, Value and Gross Margin (2021-2026)
  59. 8.10.4 Jiangxi Zhenshiming Pharmaceutical Azelastine Product Portfolio
  60. 8.10.5 Jiangxi Zhenshiming Pharmaceutical Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Azelastine Value Chain Analysis
  2. 9.1.1 Azelastine Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Azelastine Sales Mode & Process
  6. 9.2 Azelastine Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Azelastine Distributors
  9. 9.2.3 Azelastine Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst